Biotech Values

[Biowatch]

>>Amgen to Acquire Abgenix for $22.50 Per Share<<

That's a very hefty premium. They get the manufacturing facilities too, as well as Pani and presumably the technology and IP to create fully human monoclonal antibodies.

Dew, weren't you also one of the ones who thought the Pani data wasn't good enough, or the press release not clear enough?